FLGT

$0.00

(

+0.00%

) Quote details
Add to Watchlist Run Backtest
stock

Fulgent Genetics Inc

NASDAQ | FLGT

23.74

USD

+$0.00

(

+0.00%

)

At Close (As of Oct 24, 2025)

$722.99M

Market Cap

-

P/E Ratio

-1.66

EPS

$24.64

52 Week High

$14.57

52 Week Low

HEALTHCARE

Sector

FLGT Chart

Recent Chart
Price Action

FLGT Technicals

Tags:

FLGT Earnings

Yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $107M
Total Revenue $283M
Cost Of Revenue $176M
Costof Goods And Services Sold $176M
Operating Income -$74M
Selling General And Administrative $88M
Research And Development $49M
Operating Expenses $181M
Investment Income Net -
Net Interest Income $31M
Interest Income $31M
Interest Expense $170K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $25M
Income Before Tax -$52M
Income Tax Expense -$8.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$44M
Comprehensive Income Net Of Tax -
Ebit -$74M
Ebitda -$49M
Net Income -$43M

Revenue & Profitability

Earnings Performance

FLGT Financials

yearly Balance Sheet (As of Dec 31, 2024)

Field Value (USD)
Total Assets $1.2B
Total Current Assets $354M
Cash And Cash Equivalents At Carrying Value $55M
Cash And Short Term Investments $55M
Inventory $8.4M
Current Net Receivables $69M
Total Non Current Assets $866M
Property Plant Equipment -
Accumulated Depreciation Amortization Ppe -
Intangible Assets $135M
Intangible Assets Excluding Goodwill $135M
Goodwill $22M
Investments -
Long Term Investments $570M
Short Term Investments $203M
Other Current Assets $30M
Other Non Current Assets -
Total Liabilities $91M
Total Current Liabilities $73M
Current Accounts Payable $18M
Deferred Revenue -
Current Debt -
Short Term Debt $412K
Total Non Current Liabilities $18M
Capital Lease Obligations $5.6M
Long Term Debt $2.5M
Current Long Term Debt $412K
Long Term Debt Noncurrent -
Short Long Term Debt Total $9.2M
Other Current Liabilities $24M
Other Non Current Liabilities $4.9M
Total Shareholder Equity $1.1B
Treasury Stock -
Retained Earnings $590M
Common Stock $3K
Common Stock Shares Outstanding $30M

yearly Cash Flow (As of Dec 31, 2024)

Field Value (USD)
Operating Cashflow $21M
Payments For Operating Activities -
Proceeds From Operating Activities -
Change In Operating Liabilities -
Change In Operating Assets -
Depreciation Depletion And Amortization $25M
Capital Expenditures $40M
Change In Receivables -
Change In Inventory -
Profit Loss -
Cashflow From Investment -$58M
Cashflow From Financing -$4.8M
Proceeds From Repayments Of Short Term Debt -
Payments For Repurchase Of Common Stock -
Payments For Repurchase Of Equity -
Payments For Repurchase Of Preferred Stock -
Dividend Payout -
Dividend Payout Common Stock -
Dividend Payout Preferred Stock -
Proceeds From Issuance Of Common Stock -
Proceeds From Issuance Of Long Term Debt And Capital Securities Net -
Proceeds From Issuance Of Preferred Stock -
Proceeds From Repurchase Of Equity -$3.1M
Proceeds From Sale Of Treasury Stock -
Change In Cash And Cash Equivalents -
Change In Exchange Rate -
Net Income -$44M

yearly Income Statement (As of Dec 31, 2024)

Field Value (USD)
Gross Profit $107M
Total Revenue $283M
Cost Of Revenue $176M
Costof Goods And Services Sold $176M
Operating Income -$74M
Selling General And Administrative $88M
Research And Development $49M
Operating Expenses $181M
Investment Income Net -
Net Interest Income $31M
Interest Income $31M
Interest Expense $170K
Non Interest Income -
Other Non Operating Income -
Depreciation -
Depreciation And Amortization $25M
Income Before Tax -$52M
Income Tax Expense -$8.1M
Interest And Debt Expense -
Net Income From Continuing Operations -$44M
Comprehensive Income Net Of Tax -
Ebit -$74M
Ebitda -$49M
Net Income -$43M

FLGT News

FLGT Profile

Fulgent Genetics Inc Profile

Sector: HEALTHCARE

Industry: DIAGNOSTICS & RESEARCH

Fulgent Genetics, Inc. is a leading provider of advanced genetic testing and diagnostic solutions, headquartered in Temple City, California. The company utilizes innovative technology to offer a wide range of testing services, including comprehensive genomics and COVID-19 diagnostics, aimed at delivering clinically actionable insights for healthcare providers. Fulgent's commitment to precision and innovation positions it as a key player in the rapidly advancing fields of genetic medicine and public health, poised for continued growth in an ever-evolving market.

BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
WGRX
+185.43%
$1.14
TOVX
+1.63%
$0.34
YYAI
-14.98%
$0.07
VIVK
+11.91%
$0.29
F
+12.07%
$13.83
INTC
+0.31%
$38.28
YDKG
-15.04%
$0.06
BURU
+15.68%
$0.39
CGBS
-39.47%
$0.03
CENN
-0.74%
$0.21
DVLT
+43.15%
$3.22
VHAI
0.00%
$0.00
ASST
+27.28%
$1.10
NVDA
+2.25%
$186.26
NOK
+11.17%
$6.17
BITF
+10.68%
$4.61
TSLA
-3.39%
$433.72
AAL
+7.90%
$13.78
DNN
+3.29%
$2.82
RGTI
-1.90%
$38.84
ADTX
-28.06%
$0.21
T
+2.21%
$25.16
PLUG
+2.43%
$2.95
AMD
+7.63%
$252.92
RIG
+0.77%
$3.92
AXDX
-61.36%
$0.03
ABEV
-1.13%
$2.18
QBTS
+5.15%
$32.65
RF
+1.95%
$24.57
SMCI
-8.72%
$47.92
LAES
+22.55%
$7.01
CAN
+7.38%
$1.89
SOFI
+3.31%
$29.01
GRAB
+1.77%
$5.72
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
NUAI
+48.35%
$5.86
WTO
-7.14%
$0.06
TLRY
+0.67%
$1.49
QS
+14.73%
$16.82
SNAP
+1.01%
$7.95
CIFR
+19.73%
$20.66
JOBY
+1.29%
$15.67
ADAP
-7.57%
$0.06
AIRE
-22.42%
$0.76
ETHD
-3.40%
$3.83
ACHR
+3.52%
$11.29
IONZ
-4.02%
$3.82
RMBL
+60.50%
$3.21
AMZN
+1.41%
$224.21
RXRX
+5.41%
$6.04
NIO
+0.21%
$6.90
AAPL
+1.24%
$262.82
ADD
-25.47%
$0.05
VLY
+4.24%
$10.56
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
GPUS
-0.28%
$0.38
RR
+12.17%
$6.08
AMC
-1.64%
$2.68
SRM
+53.27%
$10.30
PLTR
+2.29%
$184.63
NVTS
+3.37%
$14.07
BTBT
+4.97%
$3.90
UUUU
+0.47%
$21.36
BTG
-0.47%
$5.20
DFLI
+13.27%
$1.28
RVPH
+18.99%
$0.67
BBD
+0.14%
$3.35
HPE
+0.43%
$23.19
MARA
+1.66%
$19.54
CUTR
-10.19%
$0.09
PBR
-0.84%
$11.74
NAKA
+5.66%
$0.84
WU
+10.13%
$8.96
WLGS
-5.57%
$0.04
SOUN
-1.42%
$17.98
SCWO
+32.07%
$0.48
VZ
+1.14%
$38.84
PFE
+0.44%
$24.78
IONQ
+1.63%
$60.34
ETWO
0.00%
$3.30
RGTZ
+3.08%
$15.36
MU
+5.95%
$219.02
APLD
+9.01%
$33.38
RIVN
-0.67%
$13.00
WBD
-0.47%
$21.15
LUMN
+3.78%
$8.08
HOOD
+4.06%
$139.79
SMR
+0.37%
$37.70
IVZ
+1.43%
$23.00
AFMD
-34.94%
$0.18
BMNR
+2.25%
$50.30
ERIC
-0.31%
$9.44
KDLY
+10.41%
$0.79
MSAI
-28.77%
$0.96
BAC
+1.55%
$52.56
WULF
+5.67%
$13.61
BYND
-20.67%
$2.84
SCNX
+354.94%
$2.60
WGRX
+185.43%
$1.14
TOVX
+1.63%
$0.34
YYAI
-14.98%
$0.07
VIVK
+11.91%
$0.29
F
+12.07%
$13.83
INTC
+0.31%
$38.28
YDKG
-15.04%
$0.06
BURU
+15.68%
$0.39
CGBS
-39.47%
$0.03
CENN
-0.74%
$0.21
DVLT
+43.15%
$3.22
VHAI
0.00%
$0.00
ASST
+27.28%
$1.10
NVDA
+2.25%
$186.26
NOK
+11.17%
$6.17
BITF
+10.68%
$4.61
TSLA
-3.39%
$433.72
AAL
+7.90%
$13.78
DNN
+3.29%
$2.82
RGTI
-1.90%
$38.84
ADTX
-28.06%
$0.21
T
+2.21%
$25.16
PLUG
+2.43%
$2.95
AMD
+7.63%
$252.92
RIG
+0.77%
$3.92
AXDX
-61.36%
$0.03
ABEV
-1.13%
$2.18
QBTS
+5.15%
$32.65
RF
+1.95%
$24.57
SMCI
-8.72%
$47.92
LAES
+22.55%
$7.01
CAN
+7.38%
$1.89
SOFI
+3.31%
$29.01
GRAB
+1.77%
$5.72
QLGN
+3.11%
$3.64
ONDS
+5.66%
$7.46
NUAI
+48.35%
$5.86
WTO
-7.14%
$0.06
TLRY
+0.67%
$1.49
QS
+14.73%
$16.82
SNAP
+1.01%
$7.95
CIFR
+19.73%
$20.66
JOBY
+1.29%
$15.67
ADAP
-7.57%
$0.06
AIRE
-22.42%
$0.76
ETHD
-3.40%
$3.83
ACHR
+3.52%
$11.29
IONZ
-4.02%
$3.82
RMBL
+60.50%
$3.21
AMZN
+1.41%
$224.21
RXRX
+5.41%
$6.04
NIO
+0.21%
$6.90
AAPL
+1.24%
$262.82
ADD
-25.47%
$0.05
VLY
+4.24%
$10.56
QUBT
-2.57%
$15.53
IREN
+12.60%
$62.90
GPUS
-0.28%
$0.38
RR
+12.17%
$6.08
AMC
-1.64%
$2.68
SRM
+53.27%
$10.30
PLTR
+2.29%
$184.63
NVTS
+3.37%
$14.07
BTBT
+4.97%
$3.90
UUUU
+0.47%
$21.36
BTG
-0.47%
$5.20
DFLI
+13.27%
$1.28
RVPH
+18.99%
$0.67
BBD
+0.14%
$3.35
HPE
+0.43%
$23.19
MARA
+1.66%
$19.54
CUTR
-10.19%
$0.09
PBR
-0.84%
$11.74
NAKA
+5.66%
$0.84
WU
+10.13%
$8.96
WLGS
-5.57%
$0.04
SOUN
-1.42%
$17.98
SCWO
+32.07%
$0.48
VZ
+1.14%
$38.84
PFE
+0.44%
$24.78
IONQ
+1.63%
$60.34
ETWO
0.00%
$3.30
RGTZ
+3.08%
$15.36
MU
+5.95%
$219.02
APLD
+9.01%
$33.38
RIVN
-0.67%
$13.00
WBD
-0.47%
$21.15
LUMN
+3.78%
$8.08
HOOD
+4.06%
$139.79
SMR
+0.37%
$37.70
IVZ
+1.43%
$23.00
AFMD
-34.94%
$0.18
BMNR
+2.25%
$50.30
ERIC
-0.31%
$9.44
KDLY
+10.41%
$0.79
MSAI
-28.77%
$0.96
BAC
+1.55%
$52.56
WULF
+5.67%
$13.61
2025 © AfterPullback LTD

Charts powered by TradingView

Market data may be delayed by 15 minutes or more and is provided by financial exchanges or third-party providers. AfterPullback does not verify or guarantee its accuracy and assumes no responsibility to do so. This website is not operated by a licensed attorney, accountant, or financial advisor. Nothing on this site constitutes financial advice or replaces consultation with a qualified professional who understands your specific circumstances. Always consult a licensed financial advisor before making investment decisions.